Acquisition by Santosh Shanbhag of 69750 shares of Akili subject to Rule 16b-3
AKLIDelisted Stock | USD 0.43 0.00 0.00% |
Under 56% of Akili's investor base is looking to short. The analysis of current outlook of investing in Akili Inc suggests that many traders are alarmed regarding Akili's prospects. Akili's investing sentiment shows overall attitude of investors towards Akili Inc.
Akili |
Filed transaction by Akili Inc officer. Grant, award or other acquisition pursuant to Rule 16b-3(d)
Read at macroaxis.com
Akili Fundamental Analysis
We analyze Akili's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Akili using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Akili based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Cash Per Share
Cash Per Share Comparative Analysis
Akili is currently under evaluation in cash per share category among its peers. Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.
Akili Inc Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Akili stock to make a market-neutral strategy. Peer analysis of Akili could also be used in its relative valuation, which is a method of valuing Akili by comparing valuation metrics with similar companies.
Peers
Akili Related Equities
ACON | Aclarion | 5.88 | ||||
EUDA | EUDA Health | 2.55 | ||||
HCAT | Health Catalyst | 2.08 | ||||
FOXO | FOXO Technologies | 1.96 | ||||
NRC | National Research | 0.92 | ||||
HSTM | HealthStream | 0.21 | ||||
HQY | HealthEquity | 0.91 | ||||
FORA | Forian | 1.90 | ||||
STRM | Streamline Health | 5.76 |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Consideration for investing in Akili Stock
If you are still planning to invest in Akili Inc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Akili's history and understand the potential risks before investing.
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Equity Valuation Check real value of public entities based on technical and fundamental data |